SCHEMBL21098342

SCHEMBL21098342

Cc1nc2c(C3CC3)cc(C(C)C)cc2s1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
NPC1 O15118 4/20 0.33
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SCN4A P35499 1/20 0.33
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21161224 0.81 NPC1 (0.32) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL20049390 0.81 CHRNB2 (0.39) CHRNB2CHRNA4NPC1RAB9ASMN1; SMN2
SCHEMBL21098334 0.78 CHRNB2 (0.37) CHRNB2CHRNA4NPC1RAB9ASMN1; SMN2
SCHEMBL20049335 0.77 GAA (0.41) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL21097746 0.76 CHRNB2 (0.35) CHRNB2CHRNA4NPC1RAB9ASMN1; SMN2
SCHEMBL20049459 0.76 CHRNB2 (0.35) CHRNB2CHRNA4NPC1RAB9ASMN1; SMN2
SCHEMBL25749135 0.76 NPC1 (0.38) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL12109865 0.74 NPC1 (0.37) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL20049190 0.74 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL20667373 0.74 ALDH1A1 (0.39) NPC1RAB9ASMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019118571-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2019-06-20 WO disclosed